Tesamorelin GHRH Growth Hormone Releasing Factor Analogue

Tesamorelin GHRH Growth Hormone Releasing Factor Analogue for sale

What is Tesamorelin ?

Tesamorelin (trade name Egrifta) is a synthetic form of growth-hormone-releasing hormone (GHRH) which is used in the treatment of HIV-associated lipodystrophy. The drug is a synthetic peptide consisting of all 44 amino acids of human GHRH with the addition of a trans-3-hexenoic acid group.

Nome do Produto: Tesamorelin
CAS: 218949-48-5
Fórmula molecular: C221H366N72O67S.xC2H4O (x ≈ 7)
Peso molecular: 5135.9

Tesamorelin can not only adjust the body growth hormone secretion to normal level, but also increased visceral adipose tissue (VAT) decreased, and can improve dyslipidemia and quality of life, maintain glucose homeostasis. The drug was approved by the FDA in November 2010 for marketing of HIV-associated lipodystrophy syndrome. It is For the treatment of abdominal hyperlipidemia in HIV-infected patients with lipodystrophy, but not recommended for weight loss.

Peptídeo OEM: Fornecemos hormônio peptídico há anos, Tesamorelin GHRH Growth Hormone Releasing Factor Analogue for sale. podemos fazer produção personalizada para alguns peptídeos em 0,1 mg,0.5mg,1mg,2mg,5mg,10mg/frasco se precisar, com qualquer cor de tampas filp off.

A forma de peptídeo em pó e a combinação de peptídeos com vários ingredientes estão disponíveis. (a produção personalizada é apenas para a quantidade de peptídeo de ingrediente ativo acima 1 grama )